ANIX · Anixa Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| Lewis H. Titterton Jr. Director | ▲ Buy | Open Market | 1,046,003 Shares held | 9/23/2026 | View profile |
| Amit Kumar Chief Executive Officer | ▲ Buy | Open Market | 672,000 Shares held | 9/24/2026 | View profile |
| Arnold M. Baskies Director | ▲ Buy | Open Market | 140,572 Shares held | 9/24/2026 | View profile |
| Michael Catelani President, COO, & CFO | ▲ Buy | Open Market | 50,000 Shares held | 9/30/2026 | View profile |
Transaction History
| Michael Catelani | ▲ Buy | Open Market | 5,500 | $16K | 9/30/2026 |
| Amit Kumar | ▲ Buy | Open Market | 7,000 | $19K | 9/24/2026 |
| Arnold M. Baskies | ▲ Buy | Open Market | 5,000 | $14K | 9/24/2026 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 49,036 | $132K | 9/23/2026 |
| Amit Kumar | ▲ Buy | Open Market | 5,000 | $14K | 9/10/2026 |
| Amit Kumar | ▲ Buy | Open Market | 3,000 | $8K | 9/10/2026 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 10,000 | $27K | 9/10/2026 |
| Amit Kumar | ▲ Buy | Open Market | 5,000 | $17K | 7/31/2026 |
| Arnold M. Baskies | ▲ Buy | Option Exercise | 6,000 | $19K | 7/27/2026 |
| Arnold M. Baskies | ▼ Sell | Tax Withholding | 5,428 | $19K | 7/27/2026 |
| Amit Kumar | ▲ Buy | Open Market | 5,000 | $17K | 7/27/2026 |
| Amit Kumar | ▲ Buy | Open Market | 3,188 | $11K | 7/27/2026 |
| Amit Kumar | ▲ Buy | Open Market | 3,000 | $11K | 7/24/2026 |
| Amit Kumar | ▲ Buy | Open Market | 5,000 | $17K | 7/20/2026 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 12,000 | $42K | 7/20/2026 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 2,797 | $9K | 7/15/2026 |
| Amit Kumar | ▲ Buy | Open Market | 5,000 | $15K | 7/10/2026 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 2,836 | $7K | 6/16/2026 |
| Amit Kumar | ▲ Buy | Open Market | 21,000 | $53K | 6/12/2026 |
| Arnold M. Baskies | ▲ Buy | Open Market | 10,000 | $30K | 1/28/2026 |
| Lewis H. Titterton Jr. | ▲ Buy | Option Exercise | 16,000 | $47K | 12/15/2025 |
| Amit Kumar | ▲ Buy | Option Exercise | 200,000 | $584K | 10/30/2025 |
| Amit Kumar | ▼ Sell | Tax Withholding | 169,439 | $688K | 10/30/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 10,000 | $31K | 7/31/2025 |
| Amit Kumar | ▲ Buy | Open Market | 5,000 | $16K | 7/30/2025 |
| Arnold M. Baskies | ▲ Buy | Open Market | 5,000 | $17K | 7/18/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 10,000 | $31K | 7/11/2025 |
| Amit Kumar | ▲ Buy | Open Market | 5,000 | $16K | 7/11/2025 |
| Amit Kumar | ▲ Buy | Open Market | 10,000 | $29K | 6/4/2025 |
| Arnold M. Baskies | ▲ Buy | Open Market | 5,000 | $14K | 1/28/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 1,000 | $3K | 1/24/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 2,000 | $6K | 1/23/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 2,000 | $6K | 1/22/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 6,000 | $16K | 1/21/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 10,000 | $26K | 1/17/2025 |
| Amit Kumar | ▲ Buy | Open Market | 43,000 | $96K | 1/15/2025 |
| Michael Catelani | ▲ Buy | Open Market | 9,289 | $20K | 1/15/2025 |
| Lewis H. Titterton Jr. | ▲ Buy | Option Exercise | 16,000 | $41K | 10/22/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 5,580 | $18K | 7/31/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 21,646 | $66K | 7/30/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 7,700 | $23K | 7/26/2024 |
| Arnold M. Baskies | ▲ Buy | Open Market | 5,000 | $15K | 7/26/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 796 | $2K | 7/25/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 4,000 | $11K | 6/14/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 405 | $1K | 6/13/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 7,102 | $19K | 6/11/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 330 | $858 | 6/10/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 10,738 | $27K | 6/7/2024 |
| Michael Catelani | ▲ Buy | Open Market | 6,250 | $15K | 6/7/2024 |
| Amit Kumar | ▲ Buy | Open Market | 25,000 | $60K | 6/7/2024 |
| Michael Catelani | ▲ Buy | Grant | 1,189 | $3K | 4/30/2024 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 15,009 | $49K | 4/9/2024 |
| Arnold M. Baskies | ▲ Buy | Open Market | 10,000 | $36K | 3/15/2024 |
| Amit Kumar | ▲ Buy | Open Market | 30,000 | $97K | 3/15/2024 |
| Michael Catelani | ▲ Buy | Grant | 1,117 | $3K | 10/31/2023 |
| Lewis H. Titterton Jr. | ▲ Buy | Option Exercise | 16,000 | $41K | 10/10/2023 |
| Amit Kumar | ▼ Sell | Open Market | 11,800 | $42K | 7/31/2023 |
| Amit Kumar | ▼ Sell | Tax Withholding | 28,375 | $103K | 7/28/2023 |
| Amit Kumar | ▲ Buy | Option Exercise | 40,000 | $103K | 7/28/2023 |
| Lewis H. Titterton Jr. | ▲ Buy | Option Exercise | 120,000 | $309K | 7/27/2023 |
| Lewis H. Titterton Jr. | ▼ Sell | Tax Withholding | 87,042 | $309K | 7/27/2023 |
| Michael Catelani | ▲ Buy | Open Market | 5,500 | $20K | 7/20/2023 |
| Michael Catelani | ▲ Buy | Grant | 865 | $3K | 4/28/2023 |
| Michael Catelani | ▼ Sell | Other | 1,069 | $3K | 10/31/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Option Exercise | 40,000 | $103K | 9/29/2022 |
| Amit Kumar | ▲ Buy | Option Exercise | 640,000 | $1.6M | 9/15/2022 |
| Amit Kumar | ▼ Sell | Tax Withholding | 491,900 | $2.2M | 9/15/2022 |
| Lewis H. Titterton Jr. | ▼ Sell | Gift | 300,000 | $0 | 9/14/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Option Exercise | 30,000 | $77K | 6/24/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Option Exercise | 16,000 | $41K | 6/24/2022 |
| Michael Catelani | ▼ Sell | Other | 1,086 | $3K | 4/29/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 10,000 | $28K | 4/26/2022 |
| Michael Catelani | ▲ Buy | Open Market | 5,500 | $15K | 4/21/2022 |
| Michael Catelani | ▲ Buy | Open Market | 2,509 | $6K | 4/20/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 5,000 | $16K | 1/12/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 2,000 | $6K | 1/11/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 6,000 | $18K | 1/10/2022 |
| Amit Kumar | ▲ Buy | Open Market | 20,000 | $60K | 1/7/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 11,000 | $34K | 1/7/2022 |
| Lewis H. Titterton Jr. | ▲ Buy | Open Market | 18,244 | $87K | 10/29/2021 |
| Amit Kumar | ▲ Buy | Open Market | 2,000 | $10K | 10/29/2021 |
| Michael Catelani | ▼ Sell | Other | 743 | $3K | 10/29/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Anixa Biosciences Secures First Australian Patent for Breast Cancer Vaccine
Anixa Biosciences received its first Australian patent for its breast cancer vaccine technology, extending global protection through 2040. This milestone strengthens the company's intellectual property position for a product exclusively licensed from the Cleveland Clinic. While HC Wainwright & Co. recently lowered its price target to $6, the patent grant provides a concrete regulatory and legal development for the stock.
Anixa Biosciences Secures First Australian Patent for Breast Cancer Vaccine. Anixa Biosciences received its first Australian patent for its breast cancer vaccine technology, extending global protection through 2040. This milestone strengthens the company's intellectual property position for a product exclusively licensed from the Cleveland Clinic. While HC Wainwright & Co. recently lowered its price target to $6, the patent grant provides a concrete regulatory and legal development for the stock.